Clinical Trial Update: Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing convalescent plasma to human immunoglobulin for COVID-19 pneumonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Drugs mentioned

• Convalescent Plasma (convalescent plasma)
• Human immunoglobulin (immunoglobulin)

Snippet

Sponsor: Centenario Hospital Miguel Hidalgo | Conditions: COVID-19 Pneumonia | Phase 3 | Status: COMPLETED